1. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study. Issue 1 (December 2016) Authors: Steensma, David; Abedi, Medrdad; Bejar, Rafael; Cogle, Christopher; Foucar, Kathryn; Garcia-Manero, Guillermo; George, Tracy; Grinblatt, David; Komrokji, Rami; Ma, Xiaomei; Maciejewski, Jaroslaw; Pollyea, Daniel; Savona, Michael; Scott, Bart; Sekeres, Mikkael; Thompson, Michael; Swern, Arlene; Ni... Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. De novo acute myeloid leukemia with 20–29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study. Issue 11 (31st July 2014) Authors: Hasserjian, Robert Paul; Campigotto, Federico; Klepeis, Veronica; Fu, Bin; Wang, Sa A.; Bueso‐Ramos, Carlos; Cascio, Michael Joseph; Rogers, Heesun Joyce; Hsi, Eric Darryl; Soderquist, Craig; Bagg, Adam; Yan, Jiong; Ochs, Rachel; Orazi, Attilio; Moore, Frank; Mahmoud, Amer; George, Tracy Irene; F... Journal: American journal of hematology Issue: Volume 89:Issue 11(2014:Nov.) Page Start: E193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Myelodysplastic Syndromes An Issue of Hematology/Oncology Clinics of North America, E-Book. (2020) Authors: Steensma, David Record Type: Book Extent: 1 online resource (240 pages) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Outcome of lower-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS) after failure of erythropoiesis- stimulating agents. (December 2020) Authors: Park, Sophie; Hamel, Jean-François; Toma, Andrea; Kelaidi, Charikleia; Thépot, Sylvain; Campelo, Maria Díez; Santini, Valeria; Sekeres, Mikkael A.; Komrokji, Rami; Steensma, David; Balleari, Enrico; Götze, Katharina S.; Kotsianidis, Ioannis; Guerci- Bresler, Agnès; Stamatoullas, Aspasia; Sanz, Gu... Journal: Leukemia research Issue: Volume 99(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognosis of patients with intermediate risk IPSS‐R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS‐R. Issue 10 (26th September 2018) Authors: Benton, Christopher B.; Khan, Maliha; Sallman, David; Nazha, Aziz; Nogueras González, Graciela M.; Piao, Jin; Ning, Jing; Aung, Fleur; Al Ali, Najla; Jabbour, Elias; Kadia, Tapan M.; Borthakur, Gautam; Ravandi, Farhad; Pierce, Sherry; Steensma, David; DeZern, Amy; Roboz, Gail; Sekeres, Mikkael; A... Journal: American journal of hematology Issue: Volume 93:Issue 10(2018:Oct.) Page Start: 1245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?. Issue 11 (19th September 2021) Authors: Komrokji, Rami; Al Ali, Najla; Padron, Eric; Lancet, Jeffrey; Nazha, Aziz; Steensma, David; DeZern, Amy; Roboz, Gail; Garcia-Manero, Guillermo; Sekeres, Mikkael A.; Sallman, David Journal: Leukemia & lymphoma Issue: Volume 62:Issue 11(2021) Page Start: 2762 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗